共 50 条
- [1] A modified IL-18 drug in combination with CTLA-4 blockade enhances anti-tumor efficacy in preclinical models of renal cell carcinoma ONCOLOGIST, 2023, 28 : S7 - S7
- [4] Blockade of focal adhesion kinase (FAK) has potent anti-tumor activities in human renal cell carcinoma JOURNAL OF UROLOGY, 2008, 179 (04): : 36 - 36
- [7] Anti-tumor effect of ribavirin in combination with interferon-α on renal cell carcinoma cell lines in vitro Cancer Cell International, 14